How have GERN and SANA total returns compared?

Over the past 5 years, GERN delivered -1.87% and SANA delivered -32.33% annualized total return. Past performance doesn't predict future results.

Geron Corporation (GERN) vs Sana Biotechnology, Inc. (SANA)

A side-by-side comparison of Geron Corporation and Sana Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GERN

Geron Corporation

$783M

$1.22HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

SANA

Sana Biotechnology, Inc.

$776M

$2.79HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT

Total return — GERN vs SANA

growth of $100 · dividends reinvested · last 6y

GERN -36.3% (-7.2%/yr)SANA -91.8% (-34.1%/yr)GERN compounded faster over this window

Log scale — wide-divergence pair

GERN SANA

GERN vs SANA: by the numbers

•GERN is the larger company ($783M vs $776M market cap).
•Both run net losses; SANA's is the smaller (0.00% vs -34.17% net margin).

Metrics side by side

Valuation

Metric	GERN	SANA
P/S ratio	3.83	N/A
P/B ratio	3.58	5.02

Profitability

Metric	GERN	SANA
Gross margin	97.42%	0.00%
Operating margin	-29.28%	0.00%
Net margin	-34.17%	0.00%
ROE	-31.97%	-137.04%
ROIC	-8.34%	-67.58%

Growth (annualized)

Metric	GERN	SANA
Revenue CAGR (5Y)	247.85%	N/A
Total return CAGR (5Y)	-1.87%	-32.33%

Frequently asked

How have GERN and SANA total returns compared?: Over the past 5 years, GERN delivered -1.87% and SANA delivered -32.33% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GERN analysis Full SANA analysis Interactive comparison tool

Dig into the metrics

Geron ROE Sana Biotechnology ROE Geron operating margin Sana Biotechnology operating margin Geron revenue growth Sana Biotechnology revenue growth Geron free cash flow Sana Biotechnology free cash flow

Geron & Sana Biotechnology appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.